Nagae S, Hori Y
Department of Dermatology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Dermatol. 1998 Nov;25(11):706-9. doi: 10.1111/j.1346-8138.1998.tb02488.x.
Tranilast (Rizaben)-induced thrombocytopenia occurring in a 17-year-old man was reported. After withdrawal of the drug, he recovered within a week with oral prednisolone administration. Serological examination revealed no anti-platelet antibody, but platelet-associated IgG (PAIgG) was found. After incubation of peripheral blood of the patient with the drug in vitro, the level of PAIgG was significantly increased. These findings suggest the presence of a drug-dependent anti-platelet IgG in the patient's serum. This is the first report of immune thrombocytopenia caused by Tranilast. Our method for detecting drug-dependent platelet antibody in vitro is safe and useful for diagnosing drug-induced thrombocytopenia.
有报道称,一名17岁男性出现了曲尼司特(利扎本)诱发的血小板减少症。停药后,他在口服泼尼松龙一周内康复。血清学检查未发现抗血小板抗体,但发现了血小板相关IgG(PAIgG)。患者外周血与该药物在体外孵育后,PAIgG水平显著升高。这些发现提示患者血清中存在药物依赖性抗血小板IgG。这是曲尼司特引起免疫性血小板减少症的首例报告。我们体外检测药物依赖性血小板抗体的方法对于诊断药物性血小板减少症安全且有用。